Bill Type
Congress Name
Long Title
AN ACT REGULATING DRUG PRICES AND PROVIDING SUPPORT FOR LOCAL DRUG MANUFACTURERS FOR THE PRODUCTION OF LOW COST, SAFE AND QUALITY MEDICINE, AND FOR OTHER PURPOSES
Date filed
September 11, 2007
Scope
Legislative History
| House Bill/Resolution NO. HB02492 | |
| FULL TITLE : AN ACT REGULATING DRUG PRICES AND PROVIDING SUPPORT FOR LOCAL DRUG MANUFACTURERS FOR THE PRODUCTION OF LOW COST, SAFE AND QUALITY MEDICINE, AND FOR OTHER PURPOSES | |
| SHORT TITLE : "Low Cost, Safe and Effective Medicines Act of 2007" | |
| ABSTRACT : The bill creates the Drug Regulatory Board that shall have the power to fix the maximum retail prices of drugs, direct manufacturers of bulk drug formulations to sell bulk drugs to other manufacturers and determine the list of selected essential medicine for selective parallel importation. | |
| PRINCIPAL AUTHOR/S : OCAMPO, SATUR C. | |
| DATE FILED : 2007-09-11 | |
| SIGNIFICANCE: NATIONAL | |
| CO-AUTHORS : | |
| 1. Casiño | 2. Maza |
| 3. Beltran | 4. Ilagan |
| CO-AUTHORS (Journal Entries) : | |
| 1. Ramiro (028 ) | 2. Colmenares (072 ) |
| ACTIONS TAKEN BY THE COMMITTEE | |
| COMMITEE HEARINGS/ACTIONS: | |
| 1. Scheduled for first meeting/hearing on 2007-09-11 | |
| 2. Under deliberation by the Mother Committee on 2007-09-19 | |
| 3. Under deliberation by the Mother Committee on 2007-09-20 | |
| 4. Under deliberation by the Mother Committee on 2007-09-24 | |
| 5. Under deliberation by the Mother Committee on 2007-09-25 | |
| 6. Under study by the Technical Working Group(TWG) on 2007-09-26 | |
| 7. Under study by the Technical Working Group(TWG) on 2007-09-27 | |
| 8. Under study by the Technical Working Group(TWG) on 2007-09-28 | |
| 9. Under deliberation by the Mother Committee on 2007-10-01 | |
| 10. Under deliberation by the Mother Committee on 2007-10-02 | |
| 11. Under deliberation by the Mother Committee on 2007-10-03 | |
| 12. Under deliberation by the Mother Committee on 2007-10-05 | |
| MOTHER BILL: HB02844 | |
| ACTIONS TAKEN BY THE COMMITTEE ON RULES | |
| REFERRAL TO THE COMMITTEE ON TRADE AND INDUSTRY ON 2007-09-19 |
Abstract
The bill creates the Drug Regulatory Board that shall have the power to fix the maximum retail prices of drugs, direct manufacturers of bulk drug formulations to sell bulk drugs to other manufacturers and determine the list of selected essential medicine for selective parallel importation.
Disclaimer
Note: Legislative history and other information accessed from Congress Legis. Information as of April 20, 2022.